MARKED CLINICAL IMPROVEMENT IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA BY SURGICAL REMOVAL OF EXTENDED TUMOR MASS IN RIGHT ATRIUM AND PULMONARY-ARTERIES

被引：19

作者：

MASAKI, N

HAYASHI, S

MARUYAMA, T

OKABE, H

MATSUKAWA, M

UNNO, J

MAEKAWA, S

OKA, T

TANI, M

MATSUEDA, K

UMEDA, N

机构：

[1] NATL MED CTR,DIV GASTROENTEROL,SHINJUKU KU,TOKYO 162,JAPAN

[2] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 1,TOKYO,JAPAN

[3] NATL MED CTR,DIV THORAC SURG,TOKYO,JAPAN

[4] NATL MED CTR,DIV PATHOL,TOKYO,JAPAN

[5] UNIV TOKYO,FAC MED,DEPT PATHOL,TOKYO,JAPAN

[6] NATL MED CTR,DIV SURG,TOKYO,JAPAN

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1994年 / 33卷

关键词：

D O I：

10.1007/BF00686660

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Two patients with advanced hepatocellular carcinoma presented severe exertional dyspnea because of extension of a tumor into the right side of the heart. Removable of the tumor thrombus by open-heart surgery ameliorated the symptoms in each case, but their subsequent courses differed considerably. One patient survived for as long as 8 months thanks to successive multidisciplinary treatments, whereas the other patient died suddenly 1 month after the surgery. The first patient's hepatocellular carcinoma was more differentiated, and the dyspnea was caused by a low cardiac output due to the intracardiac tumor mass, not by pulmonary embolism as in the second patient's case. We conclude that successive multidisciplinary treatments to control the growth of hepatocellular carcinoma is the most important approach and is indispensable for improving the prognosis.

引用

页码：S7 / &

共 3 条

[1] EFFECTIVENESS OF CHEMOEMBOLIZATION THERAPY FOR METASTATIC RIGHT ATRIAL TUMOR THROMBUS ASSOCIATED WITH HEPATOCELLULAR-CARCINOMA [J].